Anti Epilepsy Drugs Market 2018; Worldwide Key Renowned Like Johnson & Johnson, UCB Pharma, Pfizer, Shire Pharmaceuticals, Cephalon and Others - Detail Analysis and Forecasts To 2023

Global Anti-epilepsy Drugs Market - Overview

Epilepsy is a chronic disorder that causes unprovoked and recurrent seizures. Epilepsy is the fourth most common neurological disorder and affects people of all ages. The patients are reported to loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Increasing prevalence of the epilepsy, rising per capita healthcare expenditure and increasing R&D for the therapeutic procedures of the disease drives the market growth during the forecast period, 2017-2022.

Premium Sample Report Available @ https://www.marketresearchfuture.com/sample_request/2345

The global anti-epilepsy drugs market is growing with the sound pace. According to a recent study report published by the Market Research Future, The global anti-epilepsy drugs market is booming and expected to gain prominence over the forecast period growing rapidly .The market is forecasted to demonstrate a sound growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2022).

Global Anti-epilepsy Drugs Market - Scenario

Epilepsy is a group of neurological disorders characterized by seizures manifesting as brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. About 24 million people around the globe suffer from epilepsy with the global epilepsy drugs market reaching USD 3.7 billion in 2015. It is estimated that this market has the potential to reach USD 4.8 billion in 2022 representing a CAGR of 3.79%.

Global Anti-epilepsy Drugs Market - Key Players

Pfizer, Inc., Johnson & Johnson, UCB Pharma Ltd., Abbott Laboratories, GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Shire Pharmaceuticals Limited and Cephalon Inc.

Global Anti-epilepsy Drugs Market - Segments

Global anti-epilepsy drugs market has been segmented on the basis of types of seizures, generation, and region.

Global Anti-epilepsy Drugs Market - Intended Audience

Global anti-epilepsy drugs manufacturers

Global anti-epilepsy drugs suppliers

Research and development Laboratories

Market Research and Consulting Service Providers

Browse Complete Report @ https://www.marketresearchfuture.com/reports/anti-epilepsy-drugs-market-2345

The major driving factor for the growth are:

Development of better tolerated third generation drugs

Increasing screening of patients, penetration and availability of drugs

Growth of geriatrics as they are affected more by epilepsy

Comparative lower competition in anti-epilepsy drugs as most drugs act by similar action. Thus, advent of a novel drug will make it a blockbuster with easy uptake and less marketing cost

Historical dominance of Gamma Aminobutyric Acid modulators and ion channel blockers, even though a sizeable segment of patients respond very poorly or none at all to these drugs

Associated side-effects, such as depression and suicide behavior, dizziness, fatigue, weight gain etc. of major class of drugs

High cost of clinical trials and extensive post market surveillance as it is difficult to separate cause and effect of drugs in epilepsy

Social stigma associated with epilepsy especially in the developing world

Global Anti-epilepsy Drugs Market - Study Objectives

To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global anti-epilepsy drugs market

To provide insights about factors affecting the market growth

To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

To provide country level analysis of the market with respect to the current market size and future prospective

To provide country level analysis of the market for segments by type of seizures (seizures (generalized seizures and partial-onset seizures) and by generation (first, second and third)

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally. 

Global Anti-epilepsy Drugs Market - Regional Analysis

Globally, North America is the largest market for anti-epilepsy drugs. Europe is the second-largest market for anti-epilepsy drugs. The developing region especially Asia Pacific is accounting for major newer cases due to greater screening and better health care facilities distribution. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s Five Forces Model

4.1.1 Bargaining Power Of Suppliers

4.1.2 Bargaining Power Of Customer

4.1.3 Intensity Of Competitor’s

Major TOC Continued…!

Get Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/2345

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.